pharma Cancer Drug Prices: Sharp Drop in Bengaluru Brings Relief November 9, 2026 Kenneth Bennett Cancer drug prices have dropped sharply in Bengaluru, providing significant relief to patients and families.
pharma USFDA Approval for Ophthalmic Solution: Proven Benefits November 4, 2026 Kenneth Bennett USFDA approval ophthalmic solution offers new treatment options for patients.
pharma Semaglutide pill approval: A Smart Step for Diabetes Treatment November 2, 2026 Kenneth Bennett Semaglutide pill approval is set to transform diabetes management in India, offering new hope for patients.
pharma Sun Pharma Q2 profit: Is it the Worst Outcome Yet? October 30, 2026 Kenneth Bennett Sun Pharma Q2 profit has fallen 36% due to acquisition charges, despite a revenue beat. What does this mean for investors?
pharma AI Drug Review Standards: Clear Path for Safe Approval October 23, 2026 Kenneth Bennett AI drug review standards are now established, allowing for safer approval of drugs in the market.
pharma Generic drug price-fixing: South Dakota’s Smart Settlement October 11, 2026 Kenneth Bennett Generic drug price-fixing has led South Dakota to join settlements aimed at lowering costs.
pharma Korea obesity drug: Clear Approval for Proven Treatment October 8, 2026 Kenneth Bennett Korea obesity drug has received approval, promising a proven solution for weight management. Launch set for October.
pharma Brinzolamide Ophthalmic API: The Best Launch from C2 Pharma October 3, 2026 Kenneth Bennett Brinzolamide ophthalmic API is now available from C2 Pharma, offering proven solutions for eye care.
pharma Ono Pharmaceutical Excopri Approval: A Clear Positive Change September 26, 2026 Kenneth Bennett Ono Pharmaceutical Excopri approval could change the company's narrative significantly.
pharma Oncology portfolio approvals: Proven benefits for patients September 22, 2026 Kenneth Bennett Oncology portfolio approvals are crucial for advancing treatment options in Azerbaijan.
